Daiichi Life Insurance Co. Ltd. Purchases Shares of 28,452 Ventas, Inc. $VTR

Daiichi Life Insurance Co. Ltd. acquired a new position in shares of Ventas, Inc. (NYSE:VTR) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 28,452 shares of the real estate investment trust’s stock, valued at approximately $2,527,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Deutsche Bank AG lifted its stake in shares of Ventas by 0.7% during the 4th quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock worth $302,114,000 after buying an additional 27,688 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Ventas by 2.5% in the 4th quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock valued at $222,000,000 after buying an additional 70,459 shares during the last quarter. Norges Bank acquired a new position in Ventas in the 4th quarter valued at about $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Ventas by 7.4% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock worth $104,095,000 after acquiring an additional 92,236 shares during the last quarter. Finally, Cbre Investment Management Listed Real Assets LLC boosted its holdings in shares of Ventas by 5.8% during the fourth quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust’s stock worth $143,305,000 after acquiring an additional 101,370 shares during the period. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Stock Performance

Shares of NYSE:VTR opened at $93.32 on Monday. The company’s 50 day moving average price is $91.36 and its two-hundred day moving average price is $87.15. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60. The firm has a market cap of $47.87 billion, a PE ratio of 172.81, a PEG ratio of 2.15 and a beta of 0.69. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.

Ventas (NYSE:VTR) last announced its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company had revenue of $1.73 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period last year, the firm earned $0.87 earnings per share. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. Equities research analysts predict that Ventas, Inc. will post 3.89 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.53% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

VTR has been the topic of several research reports. Wells Fargo & Company upped their target price on Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Raymond James Financial began coverage on Ventas in a report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price target for the company. KeyCorp boosted their price target on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Cantor Fitzgerald upped their price objective on Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Finally, UBS Group increased their price objective on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $98.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.